Table 1. Temporary portocaval shunt during OLT with vena cava preservation.
| Parameter | PCS group | No PCS group | p value |
|---|---|---|---|
| All patients | |||
| CO decrease (%) | −9.6±23 | −19± 18 | 0.05 |
| SVR increase (%) | 22±43 | 41 ±49 | 0.07 |
| Urinary output (ml/kg/h) | 3.6 | 2.1 | 0.05 |
| OLT without transfusion (%) | 45 | 22 | 0.05 |
| Portal flow ≥ 1000 ml/min* | |||
| CO decrease (%) | −3.5±17 | −21±19 | 0.02 |
| SVR increase (%) | 27±19 | 27 ±39 | 0.9 |
| Urinary output (ml/kg/h) | 3.6 | 2.1 | 0.08 |
| OLT without transfusion (%) | 61 | 23 | 0.04 |
| P-C gradient ≥ 16 mmHg* | |||
| CO decrease (%) | −12±23 | −23±18 | 0.08 |
| SVR increase (%) | 11.3 ±34 | 50 ±50 | 0.07 |
| Urinary output (ml/kg/h) | 3.6 | 1.9 | 0.01 |
| OLT without transfusion (%) | 45 | II | 0.01 |
| Both characteristics* | |||
| CO decrease (%) | −8.8±28 | −27±17 | 0.1 |
| SVR increase (%) | 17.9±45 | 38 ±38 | 0.3 |
| Urinary output (ml/kg/h) | 5.5 | 2.1 | 0.03 |
| OLT without transfusion (%) | 67 | 15 | 0.04 |
PCS, temporary portocaval shunt. CO, cardiac output; SVR, systemic vascular resistance. CO decrease, SVR increase and urinary output refer to the anhepatic phase.
*At the beginning of OLT.